Are You in Florida for Spring Training? Come meet Globe Sports Writers Nick Cafardo and Peter Abraham! Click for more info.

mass. movers

Agenus finalizes European acquisition

Associated Press/File 2010

Continue reading below

Lexington-based Agenus Inc., which is developing novel immunotherapeutics, including anti-cancer vaccines, completed its acquisition of 4-Antibody AG, a private European biopharmaceutical company. Agenus acquired all outstanding stock of 4-Antibody for about 3.3 million shares of Agenus common stock, plus additional contingent payments that may exceed $40 million based on the combined company achieving certain milestones. Agenus intends to continue 4-Antibody’s operations in Basel, Switzerland, and Jena, Germany.

Loading comments...

Wake up with today's top stories.

Want each day's news headlines delivered fresh to your
inbox every morning? Just connect with us
in one of the following ways:
or
Please enter a valid email
BostonGlobe.com will never post anything without asking. Privacy Policy
Subscriber Log In

You have reached the limit of 5 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of BostonGlobe.com
Marketing image of BostonGlobe.com